Windtree Therapeutics Inc

-0.16 (-2.39%)
Earnings Announcements

Windtree Therapeutics Reports Q3 Loss Per Share $0.54

Published: 11/16/2020 12:51 GMT
Windtree Therapeutics Inc (WINT) - Windtree Therapeutics Reports Third Quarter 2020 Financial Results and Provides Key Business Updates.
Q3 Loss per Share $0.54.
As of September 30, 2020, Co Reported Cash and Cash Equivalents of $22.4 Million.
Will Be Able to Fund Operations Through at Least Next Twelve Months.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0.2 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.